The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.

Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...

Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical ...

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its ...

The startup’s machine learning AI models can still deliver major savings by reducing how much iteration is required to get past this bit of the drug development chain. “The inspiration for ...

Pfizer is testing multiple doses for a once-a-day version of danuglipron after scrapping the development of a twice-daily version of the drug in late 2023. Pfizer said in January that it expects ...